Navigation Links
Vermillion Announces Notice of Allowance of Patent for Breast Cancer Biomarkers
Date:2/2/2011

ual results and experience to differ materially from the anticipated results or other expectations expressed in such forward-looking statements. Factors that could cause actual results to materially differ include but are not limited to: (1) uncertainty as to Vermillion's ability to protect and promote its proprietary technology; (2) Vermillion's lack of a lengthy track record successfully developing and commercializing diagnostic products; (3) uncertainty as to whether Vermillion will be able to obtain any required regulatory approval of its future diagnostic products; (4) uncertainty of the size of market for its existing diagnostic tests or future diagnostic products, including the risk that its products will not be competitive with products offered by other companies, or that users will not be entitled to receive adequate reimbursement for its products from third party payors such as private insurance companies and government insurance plans; (5) uncertainty that Vermillion will successfully license or otherwise successfully partner with third parties to commercialize its future products; (6) uncertainty whether the trading in Vermillion's stock will become significantly less liquid; and (7) other factors that might be described from time to time in Vermillion's filings with the Securities and Exchange Commission. All information in this press release is as of the date of this report, and Vermillion expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in Vermillion's expectations or any change in events, conditions or circumstances on which any such statement is based, unless required by law.  


'/>"/>
SOURCE Vermillion, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Vermillion Announces Issuance of European Patent
2. Vermillion to Attend Society of Gynecologic Oncologists Meeting March 15-19
3. Medicare Establishes Reimbursement Coverage for Vermillions OVA1(TM) Test
4. Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors
5. Vermillion Announces Return of Eric Fung, M.D., Ph.D.
6. Vermillion, Inc. Files a Voluntary Petition for Reorganization Relief Under Chapter 11 of the United States Bankruptcy Code
7. Vermillion Announces Notice of Issuance of U.S. Patent Covering Hepcidin as a Biomarker for Ovarian Cancer
8. Vermillion Announces Receipt of NASDAQ Panel Decision
9. Vermillion and Stanford Scientists Receive Best Research Award From the PAD Coalition
10. International Isotopes Inc. Announces a Shareholder Conference Call for February 7, 2011
11. Advanced Health Media Company Announces Renee DeFranco as Senior Vice President - Human Resources
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... September 17, 2014 Beckman Coulter ... science and healthcare, has renewed its agreement with ... part of the agreement, Personify will continue to streamline ... emphasis on recruitment analytics, including time-to-fill, time-to-source and a ... our agreement with Personify was based on the success ...
(Date:9/17/2014)... The Pistoia Alliance, a global ... barriers to innovation in life sciences R&D through ... Nitsche as Executive Director Business Development North America, ... reach. , Carmen joins the Pistoia Alliance from ... At Accelrys, she managed various life sciences and ...
(Date:9/16/2014)... from jaw movements has been created by a group ... the device can generate electricity from eating, chewing and ... wearable electronic devices, such as hearing aids, cochlear implants, ... results of the device,s performance have been published today, ... and Structures . , Jaw movements have proved to ...
(Date:9/16/2014)... Rice University scientists who created a deicing film for ... as a transparent coating for glass. , The ... colleagues could keep glass surfaces from windshields to skyscrapers ... to radio frequencies (RF). , The technology was ... Applied Materials and Interfaces . , The ...
Breaking Biology Technology:Beckman Coulter Signs 3-year RPO Contract with Personify 2Beckman Coulter Signs 3-year RPO Contract with Personify 3Pistoia Alliance Expands Business Development with Appointment of Carmen Nitsche 2'Smart material' chin strap harvests energy from chewing 2Nanoribbon film keeps glass ice-free 2
... New, freely ... capture system , ... MA (PRWEB) May 10, 2010 -- Akaza Research announces the availability of the OpenClinica ... helps OpenClinica users find, share, and re-use clinical trial case report forms. It contains a ...
... GUANGZHOU, China , May 10 /PRNewswire-Asia/ -- China Medicine ... China of Western pharmaceuticals, traditional Chinese medicine,products, other nutraceuticals, medical devices, ... 9:00 a.m. Eastern,Time on Thursday, May 13, 2010 ... , , ...
... May 10 Fate Therapeutics, Inc. ... vice president of research and drug discovery.  Dr. Novak brings ... large pharmaceutical companies, including Roche and Wyeth, to apply transformative ... Novak will be responsible for Fate,s drug discovery and development ...
Cached Biology Technology:OpenClinica Case Report Form Library Now Available 2OpenClinica Case Report Form Library Now Available 3OpenClinica Case Report Form Library Now Available 4China Medicine Announces Conference Call to Discuss First Quarter 2010 Results 2Fate Therapeutics Appoints Tom Novak, Ph.D., as Vice President of Research and Drug Discovery 2Fate Therapeutics Appoints Tom Novak, Ph.D., as Vice President of Research and Drug Discovery 3
(Date:9/17/2014)... Campaigns against disposable plastic shopping bags and their environmental ... lawmakers passed the first statewide ban on the bags, ... But the plastic bag industry is not yielding without ... & Engineering News , the weekly newsmagazine of the ... with C&EN, reports that the anti-bag campaign logged its ...
(Date:9/17/2014)... Oncology-Bellvitge Biomedical Research Institute (ICO-IDIBELL), led by David ... normal accompanying cells in colorectal tumors. Analysis of ... tumors, predict the evolution of the patient and ... , Biomarkers , Colorectal cancer ... both sexes. About 30,000 new cases are diagnosed ...
(Date:9/17/2014)... [Brown University] After decades of decline, grasses have ... To the eye, the marsh in those places seems ... a key service of the marsh coastal protection ... but the ecosystem function hasn,t come back," said ecologist ... author of the study in the journal Biological ...
Breaking Biology News(10 mins):Five genes to predict colorectal cancer relapses 2Cape Cod saltmarsh recovery looks good, falls short 2Cape Cod saltmarsh recovery looks good, falls short 3
... Even moderate thyroid dysfunction during early pregnancy significantly increases ... universal screening in the first trimester, a new study ... Endocrine Society,s 94th Annual Meeting in Houston. "These ... studies that all pregnant women, irrespective of their risk ...
... Gallagher and his wife, Elizabeth, have made a $5 ... Family Professorships in Adult Stem Cell Research at the ... fund three new endowed professorships in adult and all ... Dame,s leadership in the field of stem cell research ...
... An elementary school science activity asks children who have each ... with string and tape to other "organisms" their assigned plant ... ecosystem web has been created, the teacher describes an event ... Other "organisms" that feel the tug then tug on their ...
Cached Biology News:Mild thyroid dysfunction in early pregnancy linked to serious complications 2Notre Dame establishes professorships in adult stem cell research 2Notre Dame establishes professorships in adult stem cell research 3Foundational concept of ecology tested by experiment 2Foundational concept of ecology tested by experiment 3Foundational concept of ecology tested by experiment 4
The Light Diagnostics Calicivirus Genotype 1&2 Typing OligoDetect assay is applicable for the qualitative detection of calicivirus RNA generated by an in-house validated in vitro nucleic acid amplifi...
X-Gal...
Recombinant Rat CINC-2 alpha, CF...
RABBIT ANTI SRC-RSV...
Biology Products: